Chevron’s End Means Uncertainty and Opportunity for the Healthcare Industry

“Chevron is overruled.” The U.S. Supreme Court’s June 28 decision in Loper Bright Enterprises v. Raimondo and its companion case, Relentless v. Department of Commerce, will have enormous effects on the healthcare sector….
By: Schwabe, Williamson & Wyatt PC
Previous Story

The State of Cybersecurity for Small and Medium Businesses

Next Story

Finally! FDA Issues Updated Draft Guidance on Diversity Action Plans Mandated by FDORA